Cite
Genetic signature of prostate cancer mouse models resistant to optimized hK2 targeted α-particle therapy.
MLA
Bicak, Mesude, et al. “Genetic Signature of Prostate Cancer Mouse Models Resistant to Optimized HK2 Targeted α-Particle Therapy.” Proceedings of the National Academy of Sciences of the United States of America, vol. 117, no. 26, June 2020, pp. 15172–81. EBSCOhost, https://doi.org/10.1073/pnas.1918744117.
APA
Bicak, M., Lückerath, K., Kalidindi, T., Phelps, M. E., Strand, S.-E., Morris, M. J., Radu, C. G., Damoiseaux, R., Peltola, M. T., Peekhaus, N., Ho, A., Veach, D., Hager, A.-C. M., Larson, S. M., Lilja, H., McDevitt, M. R., Klein, R. J., & Ulmert, D. (2020). Genetic signature of prostate cancer mouse models resistant to optimized hK2 targeted α-particle therapy. Proceedings of the National Academy of Sciences of the United States of America, 117(26), 15172–15181. https://doi.org/10.1073/pnas.1918744117
Chicago
Bicak, Mesude, Katharina Lückerath, Teja Kalidindi, Michael E. Phelps, Sven-Erik Strand, Michael J. Morris, Caius G. Radu, et al. 2020. “Genetic Signature of Prostate Cancer Mouse Models Resistant to Optimized HK2 Targeted α-Particle Therapy.” Proceedings of the National Academy of Sciences of the United States of America 117 (26): 15172–81. doi:10.1073/pnas.1918744117.